OA is a painful joint disease that predominantly affects the elderly. Pain is the primary symptom of OA, and it can present as either intermittent or constant. OA pain mechanisms are complex and have only recently been determined. Both peripheral and central processes are involved in creating the OA pain experience, making targeted therapy problematic. Nociceptive, inflammatory and neuropathic pains are all known to occur in OA, but to varying degrees in a patient-and time-specific manner. A better understanding of these multifactorial components of OA pain will lead to the development of more effective and safer pain treatments.
Introduction
OA is a painful chronic disease of synovial joints and the most common form of arthritis [13] . It is now considered as a disease of the whole joint, not only involving changes in the articular cartilage but also the subchondral bone, ligaments, capsule, synovial membrane and periarticular muscles [4, 5] . Additionally, it is an active dynamic alteration arising from an imbalance between repair and destruction of joint tissues and not, as commonly described, a passive degenerative disease [6] . OA reduces both the quality and quantity of life, but to date, treatment options for OA remain limited [4, 7, 8] .
Prevalence and incidence estimates for OA vary owing to different OA definitions, different joints and a heterogeneous population of patients [9] . The hand, knee and hip are most frequently affected by OA [10] , and the incidence of the disease dramatically increases with age [11] . Worldwide estimates of OA are that 9.6% of men and 18.0% of women aged 560 years have symptomatic OA [12] . It is expected to be the fourth leading cause of disability by 2020, and so it represents a major public health challenge of the future [13] .
Causes of OA
OA is a complex, heterogeneous condition and the most common cause of pain and disability in older adults [14] . OA does not result from a single cause, but rather is multifactorial in origin [15] . A wide range of systemic, genetic, biomechanical and environmental factors can contribute to the development of OA [9, 17] .
The genesis of OA involves contributions from both joint-and person-level risk factors. Old age and female gender are thought to be systemic risk factors of OA [18] . High BMI (>30 kg/m 2 ) or obesity is recognized as a potentially modifiable risk factor [19] . The OA arising from obesity is not only attributable to an increase in joint loading but is also associated with a general metabolic disturbance in these individuals. For genetic factors, 60% of hand and hip OA cases and 40% knee OA cases have relationships with genes, including those that encode for vitamin D receptor, insulin-like growth factor 1, type 2 collagen and growth differentiation factor 5 [20, 21] . Some environmental factors, such as smoking, alcohol consumption and diet, were examined in previous studies, but their roles are still unclear. Jointlevel risk factors, including joint injury, malalignment and abnormal loading of the joints, have been identified [22] . There are two major types of pain in patients with hip or knee OA: one is intermittent but severe, and the other is constant background pain or aching [25, 28] . Intermittent intense pain has the greatest impact on quality of life, especially when unpredictable. Usually, in the early stages of OA, predictable episodes of pain triggered by an activity are the distinct characteristics, whereas constant pain, particularly at night, tends to occur in the middle stages of OA. Patients with advanced stages of OA have more constant pain, with episodes of unpredictable pain [29] . Moreover, resting pain and movement pain are also two distinct characteristics of OA pain. OA pain mainly occurs during the day and typically during movement or physical activities, but many patients may exhibit resting pain at night, which is associated with advanced stages of disease [30] . The wide variety of patients with OA has been shown to respond differently to different analgesics, suggesting that there may be many distinct pain phenotypes associated with the disease [31] .
Unlike OA-related structural changes, pain is subjective and involves both peripheral and central neural mechanisms. These neurophysiological processes can be modulated not only by many neurochemical factors, but also by environmental, psychological and genetic factors (Fig. 1) [3234]. Indeed, the pain mechanisms in OA are still enigmatic [35] and require further unravelling. A more thorough understanding of the genesis of OA pain may lead to more directed mechanism-based pain therapies.
Mechanism of pain

Joint nociception
The pathological hallmark of OA is damage and remodelling of the articular joint with accompanying bone changes, such as osteophytes, sclerosis and cysts [36] . Progressive loss of articular cartilage leads to the development of joint space narrowing, which occurs contemporaneously with subchondral bone remodelling, osteophyte formation and synovitis (Table 1) [37] . Studies show that pain has a strong association with bone marrow lesions, synovitis and joint effusion, but a weaker association with cartilage damage [3841] . Inflammation plays a pivotal role in the development of OA in a subset of patients and is also a contributor to chronic pain. It triggers a cascade of events driven by inflammatory mediators, such as proteases [42] , prostaglandins [43] , neuropeptides [44] and cytokines [45] . Animal studies have demonstrated that cytokines and chemokines can participate in pain generation by acting directly on joint nociceptors [46] . Stimulation of joint nociceptors is further promoted by neovascularization of the articular cartilage and menisci, where compressive forces and hypoxia may stimulate the formation of new sensory nerves in the cartilage and menisci [4749] .
In humans, the knee joint is innervated by both sensory and sympathetic peripheral nerve fibres, which perform actions such as nociception, vasoregulation and proprioception [26] . The sensory nerves consist of thin, myelinated Ad (group III; fast conduction) and unmyelinated C (group IV; slow conduction) fibres, which innervate the joint capsule, synovium, ligaments, menisci, periosteum and subchondral bone. Thick myelinated Ab fibres (group II) that innervate synovial membrane, joint capsule, periarticular bursae, fat pad, ligaments, menisci and adjacent bone periosteum are primarliy responsible for non-noxious mechanosensation and proprioception [50] .
As articular cartilage is not innervated and is avascular in normal physiological conditions, the richly innervated tissues described above are the source of nociception in OA. Sensory and sympathetic nerves can appear in the articular cartilage in both mild and severe OA through vascular channels [51] . Ab fibres are activated by joint movement, whereas the Ad and C fibres are activated by noxious mechanical, thermal and chemical stimuli, such as inflammatory mediators [52] . Ad fibres project from the periphery to laminae I and V of the dorsal horn of the spinal cord, whereas C fibres synapse with second-order neurones in lamina II of the dorsal horn [53] .
Peripheral sensitization
In inflammatory conditions, the nociceptive system develops a state of hyperexcitability and might be activated by normally innocuous stimuli [54] . Peripheral sensitization is induced within the first hours after onset of inflammation and can persist for weeks [55] . Using in vivo electrophysiological recordings, it has been shown that joint nociceptors are sensitized in models of chemically induced and naturally occurring OA [56, 57] . The majority of joint nociceptors remain silent in normal conditions but become awakened when joint damage occurs, which conspires to intensify joint pain sensation in arthritis [24] . Many inflammatory mediators and tissue damage-associated molecular products reduce the excitation threshold in high-threshold neurones, making these joint nociceptors more likely to respond to both nonnoxious and noxious painful stimuli [58] . The signals then travel via ascending pathways to higher CNS centres, where they are interpreted as pain and assigned affective qualities. Intrinsic and extrinsic factors have the potential to alter pain sensitivity all along the pain pathway from the joint to the brain [51] .
Central sensitization OA pain is not purely peripheral, although the periphery is the source of the problem. OA pain also involves multimodality changes in nociceptive processing in the spinal cord and brain [59] . Central sensitization, in contrast to peripheral sensitization, represents an abnormal state of responsiveness or increased gain of the nociceptive system [60] . Central sensitization results from CNS plasticity, and it produces pain hypersensitivity by increasing spontaneous neuronal activity, reducing activation thresholds and expanding of the receptive field [26, 61] . Pain hypersensitivity can present with hyperalgesia (increased sensitivity to noxious stimuli), allodynia (pain in response to normally innocuous stimuli), a larger area of the pain receptive field and longer duration of pain [62, 63] . Studies show that there is discordance between pain severity and the degree of joint damage [57] . The fact that central factors play a role in OA may in part explain why co-morbid somatic symptoms associated with central pain conditions are common in OA and not caused by a purely peripheral event [64] .
Central sensitization involves excess nociceptive ascending and deficient inhibitory descending signals and is maintained by peripheral nociceptive input from the OA joint [65] . Ascending pathways arise from the dorsal horn of the spinal cord, where primary afferents make their first synapse with interneurons or projection neurones, which relay pain signals to the hypothalamus, thalamus, brainstem, amygdala and prefrontal cortex [36] .
Central sensitization has been identified in OA patients by brain imaging and qualitative sensory testing [6671] . Extensive areas of pain may be an indicator of central sensitization in patients, and pain drawings (a tool that patients with OA can use to illustrate precisely where they have felt pain during the previous week) may constitute a simple way for the early identification of central sensitization [72] . Central sensitization demonstrates a higher pain intensity and duration, a greater number of painful areas and more widespread pain [73] . A recent study found that chronic joint pain was associated with a smaller global grey matter volume in the hippocampus of women [74] . Central sensitization may even play a role in determining how much pain relief an OA patient may obtain from total knee replacement surgery [75] .
Types of OA pain
Identifying different types of OA pain is important because they will direct the basis of treatment. Nociceptive, inflammatory and neuropathic pain are distinct types of pain with distinct neurobiological mechanisms [76] . OA pain is classically considered a nociceptive pain condition arising from abnormal loading of a damaged joint. The changes in joint biomechanics will open mechanogated ion channels on nociceptive nerve endings, leading to the generation of this specific type of pain [77] . In some patients, there is an inflammatory component to their pain. As the OA joint breaks down, nerves in the subchondral bone become exposed to the intra-articular milieu, which is rich in inflammatory mediators. Sensory nerves in other joint tissues, such as the synovium and menisci, are also in contact with these pro-algesic molecules, leading to peripheral sensitization and the generation of inflammatory pain. Continuous nociceptor bombardment can lead to increased excitability of secondorder neurones in the dorsal horn of the spinal cord. This process of central sensitization augments the nociceptive signal, thereby amplifying pain sensation. Given that these second-order neurones also receive input from tissues remote from the affected joint, central sensitization is responsible for the phenomenon of referred pain [55] .
Unlike nociceptive pain, which is caused by actual tissue damage or potentially tissue-damaging stimuli, neuropathic pain is produced by damage to the nervous system itself. The definition of neuropathic pain is 'pain caused by a lesion or disease of the somatosensory system', which includes peripheral nerve fibres (Ab, Ad and C fibres) [78, 79] and nerves in the CNS [80] . During the development of OA, it has been shown that nerve damage can occur in the injured joint, in dorsal root ganglia and the spinal cord [8185] . The mechanism and mediators involved in OA nerve damage are unclear. A recent study found that the lipid mediator lysophosphatidic acid is upregulated in OA synovial fluid, where it demyelinates peripheral nerves, leading to joint neuropathic pain [86] . Peripheral neuropathic pain can be measured easily by electromyography/nerve conduction velocity recordings. Clinical features such as burning pain, paraesthesia, mechanical and thermal hyperalgesia, allodynia, paroxysmal pain and numbness can be used to distinguish neuropathic pain from chronic nociceptive pain [76] . Many screening tools, such as the Douleur Neuropathique 4 questions, the Leeds Assessment of Neuropathic Symptoms and Signs or PainDETECT scales can all be used to aid in diagnosis [79] . A recent systematic review shows that the prevalence of neuropathic pain in persons with knee or hip OA is considerable, at 23% [87] . Neuropathic pain is unresponsive to common analgesics, such as NSAIDs, so drugs such as duloxetine and systemic not local administration of lignocaine are required to manage this type of pain [71, 76, 88] .
Mediators of osteoarthritic pain
Although OA was once thought to be a non-inflammatory form of arthritis, it has long been known that pro-inflammatory agents are released into the joint, and synovitis is highly correlated with OA pain [81, 8992] . Various cytokines, proteases, neuropeptides, chemokines, prostaglandins, neurotrophins, gaseous mediators and lipids are locally released in the damaged tissue, which induce a cascade of events that lead to peripheral sensitization [9395] . These mediators reduce the mechanical threshold of joint nociceptors, leading to the initiation of nociception and joint pain [24, 44] . A recent study revealed that IL-6 and IL-8 were associated with pain during movement, whereas TNFa was associated with pain at rest and movement, suggesting that different pain mediators may be involved in specific characteristics of pain [97] . Mediators and targets of pain that are generated in dorsal root ganglia include nerve growth factor, calcitonin gene-related peptide, vasoactive intestinal peptide, vanilloid receptor 1, opioid receptors, CC-chemokine ligand 2 and its receptor, CC-chemokine receptor 2 [36, 98] . Substance P, serotonin and glutamate are mediators of osteoarthritic pain at the brain level [99, 100] . Studies show that nerve growth factor increases pain by inducing not only peripheral but also, possibly, central nerve sprouting rather than being itself directly nociceptive [101, 102] . Serine proteases such as mast cell tryptase and neutrophil elastase have been shown to be pro-nociceptive in joints by activating protease-activated receptor-2 [103, 104] . Thus, these enzymes are not only responsible for degrading joint tissues but can also act as signalling molecules to encode joint pain [42] .
Contextual aspects of pain
Numerous studies have confirmed a role for multiple psychosocial factors, such as anxiety, distress and environment, as contributing to the chronic pain experience [105, 106] . In addition to the neurophysiological processes described thus far, pain is also defined as a multidimensional and dynamic interaction among physiological, psychological and social factors known as the biopsychosocial model of pain [107, 108] . Racial/ethnic background, sleep, fatigue, obesity/BMI, psychological distress, beliefs and weather are all well-studied factors that can influence OA pain [105, 109, 110] . Many of these factors, such as depression and catastrophizing, can alter pain perception and enhance the overall pain experience [111] . Psychosocial interventions such as self-management and group support are worthwhile considerations for the effective treatment of OA pain.
Conclusion
OA is the most common joint disease worldwide, and pain is the primary symptom. OA pain is heterogeneous, varying between individuals and with different phases of the disease; these complex traits make evaluation of OA pain highly precarious. The neurobiological mechanisms of OA pain are complex and involve both peripheral and CNS processes. These, in turn, are influenced by context and a plethora of psychosocial factors. The causes of OA pain need to be elucidated, and questions such as whether OA pain can influence OA disease progression should be investigated. We still have much to study before we can truly understand the complexities of OA pain. 
